middl
east
respiratori
syndrom
coronaviru
merscov
close
resembl
sever
acut
respiratori
syndrom
coronaviru
sarscov
diseas
manifest
rapidli
progress
acut
pneumonia
multiorgan
dysfunct
use
monocytederiveddendrit
cell
modc
discov
fundament
discrep
outcom
merscovand
sarscovinfect
first
merscov
product
infect
modc
sarscovinfect
abort
second
merscov
induc
significantli
higher
level
rant
express
sarscov
third
merscovinfect
induc
higher
surfac
express
mhc
class
ii
hladr
costimulatori
molecul
sarscovinfect
overal
data
suggest
dendrit
cell
serv
import
target
viral
replic
vehicl
dissemin
merscovinfect
dc
result
product
rich
combin
cytokin
chemokin
modul
innat
immun
respons
differ
sarscovinfect
find
may
help
explain
appar
discrep
pathogen
merscov
sarscov
novel
middl
east
respiratori
syndrom
coronaviru
merscov
previous
also
known
human
coronaviru
hcov
emc
first
identifi
patient
die
sever
acut
pneumonia
renal
failur
bisha
saudi
arabia
septemb
chan
et
al
chan
et
al
de
groot
et
al
zaki
et
al
although
zoonot
sourc
suspect
bat
camel
definit
intermedi
anim
reservoir
far
confirm
may
partli
contribut
continu
spread
epidem
annan
et
al
chan
et
al
chan
kh
et
al
lau
et
al
reusken
et
al
woo
et
al
woo
et
al
februari
total
laboratoryconfirm
case
merscov
infect
fatal
report
middl
east
europ
africa
evolv
outbreak
rais
global
concern
sarslik
epidem
particularli
compar
protean
clinic
manifest
involv
respiratori
tract
extrapulmonari
tissu
unusu
high
crude
fatal
rate
among
infect
patient
assiri
et
al
chan
et
al
gueri
et
al
memish
et
al
clinic
observ
corrobor
sever
key
experiment
find
high
pathogen
merscov
first
merscov
replic
rapidli
show
much
broader
tissu
tropism
invitro
coronavirus
associ
human
infect
includ
sarscov
chan
et
al
second
use
human
lung
epitheli
cell
line
model
shown
merscov
induc
massiv
dysregul
host
transcriptom
may
prevent
host
mount
optim
immun
respons
josset
et
al
third
util
dipeptidyl
peptidas
instead
angiotensinconvert
enzym
sarscov
aminopeptidas
n
sialic
acid
function
receptor
merscov
may
also
account
differ
spectrum
organ
involv
mer
human
coronaviru
infect
du
et
al
raj
et
al
final
current
specif
antimerscov
treatment
proven
effect
clinic
trial
though
mycophenol
acid
interferon
ribavirin
cyclosporin
peptid
demonstr
invitro
activ
chan
et
al
de
wild
et
al
falzarano
et
al
lu
et
al
despit
initi
clinic
laboratori
correl
virul
merscov
remain
controversi
especi
recent
studi
report
patient
requir
hospit
die
mer
elderli
comorbid
specif
diabet
mellitu
hypertens
chronic
renal
heart
lung
diseas
assiri
et
al
contrast
healthi
children
adult
might
asymptomat
develop
mild
infect
detect
contact
trace
assiri
et
al
chan
et
al
furthermor
mani
mer
patient
develop
extrapulmonari
manifest
includ
renal
impair
hepat
dysfunct
gastrointestin
symptom
coagulopathi
cytopenia
pericard
assiri
et
al
chan
et
al
mechan
extrapulmonari
tissu
involv
mer
incomplet
understood
merscov
rna
detect
mononuclear
cell
stellat
cell
mediastin
lymph
node
infect
rhesu
macaqu
hint
possibl
macrophag
dendrit
cell
involv
indepth
studi
pathogenesi
merscov
urgent
need
ascertain
virul
pathogenet
mechan
accur
predict
clinic
behavior
better
design
therapeut
option
given
abil
merscov
infect
differ
human
immun
cell
line
includ
monocyt
lymphocyt
postul
might
also
abl
infect
dendrit
cell
dc
potent
antigen
present
cell
apc
instrument
role
link
innat
adapt
immun
system
although
previou
literatur
suggest
sarscov
unabl
establish
product
infect
dc
suspect
merscov
might
abl
infect
dc
effici
manner
due
wide
distribut
cellular
receptor
human
cell
includ
activ
leukocyt
dc
key
player
innat
immun
system
perhap
potent
apc
dc
capabl
enter
peripher
tissu
take
antigen
migrat
lymphoid
tissu
activ
helper
cell
banchereau
steinman
steinman
banchereau
capac
dc
play
uniqu
role
bridg
innat
adapt
immun
therefor
becom
import
target
microbi
invas
instanc
hiv
evolv
number
mechan
exploit
function
dc
benefit
includ
escap
immun
surveil
facilit
celltocel
dissemin
wu
kewalramani
dc
suscept
sarscov
infect
howev
suggest
number
studi
infect
either
abort
law
et
al
tseng
et
al
ziegler
et
al
low
level
spiegel
et
al
caus
advers
effect
cell
viabil
infect
dc
sarscov
fail
trigger
strong
type
interferon
ifn
respons
result
upregul
inflammatori
cytokin
chemokin
law
et
al
tseng
et
al
function
activ
dc
sarscov
analyz
result
inconclus
activ
spiegel
et
al
tseng
et
al
absenc
activ
ziegler
et
al
propos
current
studi
use
monocytederiv
dc
modc
system
recapitul
merscov
infect
dc
compar
result
sarscovinfect
modc
result
reveal
fundament
differ
replic
kinet
merscov
sarscov
infect
modc
addit
also
demonstr
characterist
chang
pattern
cytokinechemokin
express
well
antigenpres
function
infect
modc
determin
whether
primari
human
dc
suscept
merscov
infect
infect
modc
merscov
examin
express
merscov
nucleoprotein
np
differ
time
point
post
inocul
data
reveal
merscov
np
express
could
detect
hour
post
infect
hpi
fig
signal
np
appear
punctalik
distribut
cytoplasm
infect
cell
hpi
signal
np
dramat
enhanc
detect
throughout
cytoplasm
infect
cell
fig
mockinfect
cell
fig
well
cell
treat
preimmun
sera
data
shown
fail
display
signal
np
immunostain
studi
reveal
modc
suscept
merscov
infect
enhanc
express
np
hpi
versu
hpi
suggest
merscov
infect
modc
also
continu
viral
transcript
translat
infect
cell
addit
percent
modc
infect
merscov
assess
flow
cytometri
determin
hpi
data
shown
immunofluoresc
studi
describ
illustr
merscov
capabl
infect
dc
effici
transcript
translat
viral
genom
support
substanti
increas
cellular
np
express
fig
obtain
comprehens
pictur
kinet
merscov
infect
modc
infect
modc
merscov
compar
result
sarscovinfect
cell
importantli
log
increas
viral
rna
cell
lysat
fig
supernat
fig
merscovinfect
modc
detect
sampl
donor
stark
contrast
littl
increas
viral
rna
detect
cell
lysat
supernat
sarscovinfect
modc
agre
previou
report
sarscov
could
infect
unabl
propag
modc
assess
infect
viral
particl
releas
infect
modc
tcid
assay
result
demonstr
low
level
infecti
particl
detect
supernat
sarscovinfect
modc
merscovinfect
modc
consist
releas
consider
amount
infecti
particl
peak
hpi
fig
overal
data
suggest
merscov
could
establish
product
infect
modc
dc
among
first
line
innat
immun
respons
capabl
produc
larg
number
cytokin
chemokin
upon
microbi
challeng
banchereau
steinman
examin
abil
merscov
trigger
cytokin
chemokin
respons
modc
compar
result
sarscovinfect
modc
modc
infect
merscov
sarscov
tcid
per
cell
one
hour
cell
lysat
harvest
hpi
express
cytokin
chemokin
gene
quantifi
rtqpcr
normal
first
gapdh
gene
express
mockinfect
cell
data
recapitul
lack
induct
sarscovinfect
modc
time
merscov
similarli
fail
trigger
express
induc
upregul
earli
time
point
shown
fig
sarscov
margin
upregul
express
induc
upregul
hand
merscov
induc
significantli
higher
express
level
sarscov
proinflammatori
cytokin
similarli
upregul
merscovand
sarscovinfect
modc
peak
fold
induct
document
hpi
hpi
compar
level
merscov
sarscov
fig
parallel
quantifi
express
level
number
repres
inflammatori
chemotact
chemokin
includ
rant
degre
induct
merscov
sarscov
subtl
compar
level
contrast
merscov
induc
significantli
higher
level
rant
sarscov
modc
fig
dendrit
cell
profession
antigen
present
cell
play
critic
role
bridg
innat
adapt
immun
upon
activ
foreign
pathogen
dc
prime
naiv
cell
trigger
antigenspecif
cell
respons
assess
degre
activ
modc
upon
merscov
sarscov
challeng
measur
surfac
express
mhc
class
hlaabc
mhc
class
ii
hladr
costimulatori
molecul
modc
infect
merscov
sarscov
tcid
per
cell
one
hour
hpi
cell
detach
fix
immunolabel
surfac
maker
costimul
mhc
class
hlaabc
mhc
class
ii
hladr
analyz
flow
cytometri
shown
fig
surfac
express
mhc
class
hlaabc
significantli
higher
merscovinfect
modc
compar
mockinfect
sarscovinfect
modc
surfac
express
mhc
class
ii
hladr
significantli
increas
merscovinfect
modc
summari
chang
mean
fluoresc
intens
illustr
right
panel
intriguingli
littl
chang
surfac
express
mhc
costimulatori
molecul
observ
sarscovinfect
modc
fig
taken
togeth
result
demonstr
merscov
capabl
induc
modc
activ
sarscov
previou
studi
suggest
sarscov
could
infect
modc
howev
mark
reduct
viral
genom
copi
time
notabl
absenc
infecti
progeni
inocul
cell
indic
infect
low
level
spiegel
et
al
abort
law
et
al
tseng
et
al
absenc
sarscov
np
express
modc
suggest
viral
replic
cycl
incomplet
ziegler
et
al
current
studi
demonstr
conclus
merscov
could
product
infect
modc
first
immunofluoresc
studi
show
progress
increas
np
signal
infect
modc
time
fig
second
positivestrand
viral
genom
merscov
increas
log
supernat
cell
lysat
infect
modc
fig
b
third
tcid
assay
perform
use
supernat
merscovinfect
modc
demonstr
merscov
produc
substanti
amount
infecti
viru
particl
peak
product
time
around
hpi
fig
clinic
patient
contract
merscov
develop
coagulopathi
multiorgan
dysfunct
hematolog
chang
includ
lymphopenia
neutrophilia
thrombocytopenia
viru
could
detect
respiratori
tract
also
blood
gueri
et
al
urin
stool
infect
individu
strongli
argu
system
dissemin
viru
regard
merscovinfect
dc
monocytederiv
macrophag
mdm
could
potenti
serv
vehicl
dissemin
facilit
spread
viru
lymph
node
interact
cell
worsen
cytokinechemokin
storm
mimick
scenario
sar
gu
et
al
current
exact
reason
merscov
sarscov
could
product
infect
dc
unclear
differenti
infect
outcom
merscov
sarscov
may
partial
attribut
differ
level
receptor
express
li
et
al
function
receptor
sarscov
merscov
human
respect
previou
report
suggest
express
monocyt
dc
law
et
al
separ
group
suggest
could
detect
western
blot
mdm
dc
surfac
express
could
detect
flow
cytometri
tseng
et
al
analysi
rtqpcr
show
modc
express
high
level
express
level
margin
close
detect
limit
unpublish
data
addit
sarscov
use
dcsign
lsign
altern
receptor
han
et
al
jeffer
et
al
dc
known
express
abund
level
ctype
lectin
facilit
antigenuptak
figdor
et
al
instanc
dc
intern
sequest
hiv
particl
dcsign
exploit
hiv
facilit
effici
celltocel
transinfect
geijtenbeek
et
al
similar
mechan
also
util
hepat
c
viru
transinfect
liver
cell
cormier
et
al
therefor
possibl
merscov
infect
dc
viru
product
sarscov
primarili
sequest
dc
investig
possibl
necessari
dc
import
stimul
cell
b
cell
specif
immun
respons
addit
upon
encount
pathogen
dc
capabl
releas
larg
number
cytokin
chemokin
infect
modc
sarscov
induc
upregul
antivir
interferon
result
upregul
proinflammatori
cytokin
chemokin
law
et
al
tseng
et
al
recent
research
demonstr
merscov
fail
trigger
antivir
interferon
proinflammatori
innat
immun
respons
primari
human
airway
epitheli
cell
cultur
cell
chan
rw
et
al
zielecki
et
al
current
studi
report
merscov
induc
margin
express
infect
modc
merscov
induc
compar
level
proinflammatori
cytokin
compar
sarscov
parallel
express
level
chemokin
subtl
significantli
differ
merscovand
sarscovinfect
modc
importantli
merscov
trigger
significantli
higher
express
level
rant
compar
sarscovinfect
modc
fig
sarscovinfect
patient
viral
replic
limit
first
two
week
symptom
onset
without
continu
widespread
replic
period
fig
surfac
express
antigenpresent
costimulatori
molecul
modc
infect
merscov
sarscov
modc
infect
merscov
sarscov
tcid
per
cell
h
hpi
cell
detach
fix
label
specif
cellular
surfac
marker
express
surfac
marker
assess
flow
cytometri
use
bd
facscanto
ii
flow
cytomet
data
analyz
use
flowjo
number
panel
repres
mean
fluoresc
intens
fill
curv
repres
stain
isotyp
control
result
right
panel
repres
mean
mfi
sem
summar
four
independ
experi
statist
analysi
perform
group
use
student
test
p
consid
statist
signific
indic
asterisk
mark
nichol
et
al
hand
number
cytokin
chemokin
includ
limit
found
highli
upregul
sarscovinfect
patient
even
viral
clearanc
huang
et
al
jiang
et
al
wong
et
al
result
immun
dysregul
includ
mediat
cytokin
storm
might
account
larg
proport
sarsassoci
mortal
huang
et
al
current
studi
show
merscov
induc
significantli
higher
express
level
rant
infect
modc
compar
sarscov
rant
recruit
cell
mediat
differenti
naiv
cell
cell
stimul
product
cell
repres
posit
feedback
loop
data
rais
possibl
cellmedi
immun
hyperact
inflammatori
respons
merscovinfect
patient
caus
sever
diseas
host
adapt
immun
respons
could
mount
capac
profession
antigenpres
cell
dc
captur
process
endogen
exogen
antigen
present
process
antigen
mhc
class
mhc
class
ii
molecul
dc
matur
antigen
captur
process
present
accompani
increas
surfac
express
costimulatori
molecul
includ
critic
cell
signal
activ
previou
studi
perform
use
sarscovinfect
modc
indic
express
mhc
class
compar
infect
mockinfect
cell
express
mhc
class
ii
costimulatori
molecul
upregul
spiegel
et
al
tseng
et
al
although
conflict
result
exist
ziegler
et
al
studi
demonstr
merscov
induc
higher
surfac
express
mhc
class
ii
hladr
costimulatori
molecul
sarscov
infect
modc
fig
although
around
modc
infect
merscov
appear
hladr
upregul
much
larger
proport
cell
could
result
paracrin
signal
infect
modc
uninfect
cell
sinc
express
number
key
cytokin
chemokin
upregul
merscovinfect
modc
result
upregul
mhc
class
ii
hladr
costimul
molecul
robust
activ
cell
may
contribut
exagger
cell
function
may
lead
destruct
infect
pulmonari
tissu
adapt
immun
respons
mount
later
cours
ill
altern
activ
cell
also
produc
high
level
inflammatori
cytokin
may
potenti
aggrav
cytokin
cascad
taken
togeth
studi
demonstr
merscov
could
product
infect
dc
therebi
give
extra
edg
system
dissemin
sarscov
time
merscov
induc
higher
express
cytokin
chemokin
infect
dc
sarscov
compar
level
mrna
express
addit
antigenpresent
costimulatori
molecul
higher
upregul
merscovinfect
dc
sarscovinfect
dc
overal
studi
may
help
confirm
high
pathogen
merscov
explain
protean
clinic
manifest
seen
mer
investig
underli
mechan
aid
develop
effect
therapi
mer
healthi
volunt
blood
sampl
collect
hong
kong
red
cross
blood
transfus
servic
accord
protocol
approv
institut
review
board
univers
hong
kong
monocyt
prepar
differenti
perform
accord
well
establish
protocol
describ
previous
chu
et
al
brief
peripher
blood
mononuclear
cell
pbmc
obtain
buffi
coat
ficol
centrifug
allow
adher
plastic
surfac
coat
polydlysin
sigma
aldrich
saint
loui
mo
usa
h
adher
monocyt
differenti
modc
accord
establish
protocol
special
cell
treat
media
supplement
fb
ugml
streptomycin
uml
penicillin
mm
glutamin
sodium
pyruv
nonessenti
amino
acid
ngml
recombin
human
granulocyt
macrophag
colonystimul
factor
gmcsf
ngml
recombin
human
r
system
minneapoli
mn
usa
differenti
modc
modc
differenti
day
use
infect
media
replac
everi
day
viru
sarscov
cultur
cell
serum
free
dmem
supplement
penicillin
streptomycin
merscov
kindli
provid
dr
fouchier
laboratori
zaki
et
al
cultur
vero
cell
medium
two
three
day
post
infect
supernat
collect
aliquot
store
tissu
cultur
infect
dose
tcid
assay
perform
quantifi
viral
titer
infect
modc
plate
plate
infect
merscov
sarscov
tcid
cell
one
hour
supernat
cell
lysat
harvest
hpi
immunostain
modc
plate
plate
glass
cover
slip
cell
infect
merscov
tcid
cell
hpi
cell
fix
paraformaldehyd
underw
immunostain
procedur
quantif
viral
cellular
rna
transcript
rtqpcr
cellular
rna
extract
revers
transcript
quantit
pcr
perform
describ
previous
zhou
et
al
supernat
infect
cell
extract
purelink
viral
rnadna
mini
kit
life
technolog
revers
primer
np
gene
merscov
sarscov
use
retriev
cdna
complementari
posit
strand
viral
genom
oligo
dt
use
revers
transcrib
cellular
cdna
level
cellular
gene
express
normal
gapdh
present
fold
chang
gene
express
infect
modc
rel
mockinfect
modc
specif
primer
sequenc
avail
upon
request
modc
cultur
glass
cover
slip
infect
merscov
tcid
per
cell
h
hpi
cell
fix
paraformaldehyd
permeabil
block
immunostain
merscov
np
merscov
np
detect
use
guinea
pig
antinp
antibodi
previous
describ
chan
et
al
zhou
et
al
follow
fitcconjug
rabbitantiguinea
pig
igg
life
technolog
slide
mount
prolong
gold
antifad
reagent
dapi
life
technolog
examin
carl
zeiss
lsm
microscop
modc
infect
merscov
sarscov
tcid
per
cell
h
hpi
infect
cell
detach
mm
edta
fix
paraformaldehyd
immunolabel
specif
cell
surfac
marker
apcantihuman
apcantihuman
apcantihuman
hlaabc
apcantihuman
hladr
apcigg
isotyp
control
order
biolegend
sandiego
ca
usa
infect
assess
infect
modc
fix
permeabil
immunolabel
first
guinea
pig
antimerscov
np
antibodi
previous
describ
chan
et
al
zhou
et
al
follow
fitcconjug
rabbit
antiguinea
pig
igg
life
technolog
flow
cytometri
perform
use
bd
facscanto
ii
flow
cytomet
bd
bioscienc
san
jose
ca
usa
data
analyz
use
flowjo
tree
star
inc
experiment
result
repres
mean
sem
least
three
differ
donor
statist
comparison
group
perform
student
ttest
use
graphpad
prism
differ
consid
statist
signific
p
work
support
provid
foundat
limit
memori
late
dr
lui
hac
minh
hksar
health
medic
research
fund
hmrf
